BRD4 Regulates Breast Cancer Dissemination through Jagged1/Notch1 Signaling

被引:116
作者
Andrieu, Guillaume [1 ]
Tran, Anna H. [1 ]
Strissel, Katherine J. [1 ]
Denis, Gerald V. [1 ,2 ]
机构
[1] Boston Univ, Sch Med, Ctr Canc, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA
关键词
BET BROMODOMAIN INHIBITION; NOTCH LIGAND; T-CELLS; THERAPEUTIC TARGET; COLORECTAL-CANCER; DENDRITIC CELLS; INFLAMMATION; CHROMATIN; PROTEIN; KINASE;
D O I
10.1158/0008-5472.CAN-16-0559
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The bromodomain and extraterminal (BET) proteins are epigenetic "readers" of acetylated histones in chromatin and have been identified as promising therapeutic targets in diverse cancers. However, it remains unclear howindividual family members participate in cancer progression and small molecule inhibitors such as JQ1 can target functionally independent BET proteins. Here, we report a signaling pathway involving BRD4 and the ligand/receptor pair Jagged1/Notch1 that sustains triple-negative breast cancer migration and invasion. BRD4, but not BRD2 or BRD3, regulated Jagged1 expression and Notch1 signaling. BRD4-selective knockdown suppressed Notch1 activity and impeded breast cancer migration and invasion. BRD4 was required for IL6-stimulated, Notch1-induced migration and invasion, coupling microenvironment inflammation with cancer propagation. Moreover, in patients, BRD4 and Jagged1 expression positively correlated with the presence of distant metastases. These results identify a BRD4/Jagged1/Notch1 signaling pathway that is critical for dissemination of triple-negative breast cancer. (C) 2016 AACR.
引用
收藏
页码:6555 / 6567
页数:13
相关论文
共 50 条
[1]   Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer [J].
Asangani, Irfan A. ;
Dommeti, Vijaya L. ;
Wang, Xiaoju ;
Malik, Rohit ;
Cieslik, Marcin ;
Yang, Rendong ;
Escara-Wilke, June ;
Wilder-Romans, Kari ;
Dhanireddy, Sudheer ;
Engelke, Carl ;
Iyer, Mathew K. ;
Jing, Xiaojun ;
Wu, Yi-Mi ;
Cao, Xuhong ;
Qin, Zhaohui S. ;
Wang, Shaomeng ;
Feng, Felix Y. ;
Chinnaiyan, Arul M. .
NATURE, 2014, 510 (7504) :278-+
[2]   BET Protein Function Is Required for Inflammation: Brd2 Genetic Disruption and BET Inhibitor JQ1 Impair Mouse Macrophage Inflammatory Responses [J].
Belkina, Anna C. ;
Nikolajczyk, Barbara S. ;
Denis, Gerald V. .
JOURNAL OF IMMUNOLOGY, 2013, 190 (07) :3670-3678
[3]   BET domain co-regulators in obesity, inflammation and cancer [J].
Belkina, Anna C. ;
Denis, Gerald V. .
NATURE REVIEWS CANCER, 2012, 12 (07) :465-477
[4]   Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways [J].
Boelens, Mirjam C. ;
Wu, Tony J. ;
Nabet, Barzin Y. ;
Xu, Bihui ;
Qiu, Yu ;
Yoon, Taewon ;
Azzam, Diana J. ;
Victor, Christina Twyman-Saint ;
Wiemann, Brianne Z. ;
Ishwaran, Hemant ;
ter Brugge, Petra J. ;
Jonkers, Jos ;
Slingerland, Joyce ;
Minn, Andy J. .
CELL, 2014, 159 (03) :499-513
[5]   Cutting Edge: Notch Signaling Induces a Distinct Cytokine Profile in Dendritic Cells That Supports T Cell-Mediated Regulation and IL-2-Dependent IL-17 Production [J].
Bugeon, Laurence ;
Gardner, Leanne M. ;
Rose, Anna ;
Gentle, Madeleine ;
Dallman, Margaret J. .
JOURNAL OF IMMUNOLOGY, 2008, 181 (12) :8189-8193
[6]   Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors [J].
Ceribelli, Michele ;
Kelly, Priscilla N. ;
Shaffer, Arthur L. ;
Wright, George W. ;
Xiao, Wenming ;
Yang, Yibin ;
Griner, Lesley A. Mathews ;
Guha, Rajarshi ;
Shinn, Paul ;
Keller, Jonathan M. ;
Liu, Dongbo ;
Patel, Paresma R. ;
Ferrer, Marc ;
Joshi, Shivangi ;
Nerle, Sujata ;
Sandy, Peter ;
Normant, Emmanuel ;
Thomas, Craig J. ;
Staudt, Louis M. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (31) :11365-11370
[7]   Twist1 induces endothelial differentiation of tumour cells through the Jagged1-KLF4 axis [J].
Chen, Hsiao-Fan ;
Huang, Chi-Hung ;
Liu, Chung-Ji ;
Hung, Jung-Jyh ;
Hsu, Chih-Chin ;
Teng, Shu-Chun ;
Wu, Kou-Juey .
NATURE COMMUNICATIONS, 2014, 5
[8]   Bromodomain 4 activation predicts breast cancer survival [J].
Crawford, Nigel P. S. ;
Alsarraj, Jude ;
Lukes, Luanne ;
Walker, Renard C. ;
Officewala, Jennifer S. ;
Yang, Howard H. ;
Lee, Maxwell P. ;
Ozato, Keiko ;
Hunter, Kent W. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (17) :6380-6385
[9]   Silencing of Jagged1 inhibits cell growth and invasion in colorectal cancer [J].
Dai, Y. ;
Wilson, G. ;
Huang, B. ;
Peng, M. ;
Teng, G. ;
Zhang, D. ;
Zhang, R. ;
Ebert, M. P. A. ;
Chen, J. ;
Wong, B. C. Y. ;
Chan, K. W. ;
George, J. ;
Qiao, L. .
CELL DEATH & DISEASE, 2014, 5 :e1170-e1170
[10]   Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia [J].
Dawson, Mark A. ;
Prinjha, Rab K. ;
Dittmann, Antje ;
Giotopoulos, George ;
Bantscheff, Marcus ;
Chan, Wai-In ;
Robson, Samuel C. ;
Chung, Chun-wa ;
Hopf, Carsten ;
Savitski, Mikhail M. ;
Huthmacher, Carola ;
Gudgin, Emma ;
Lugo, Dave ;
Beinke, Soren ;
Chapman, Trevor D. ;
Roberts, Emma J. ;
Soden, Peter E. ;
Auger, Kurt R. ;
Mirguet, Olivier ;
Doehner, Konstanze ;
Delwel, Ruud ;
Burnett, Alan K. ;
Jeffrey, Phillip ;
Drewes, Gerard ;
Lee, Kevin ;
Huntly, Brian J. P. ;
Kouzarides, Tony .
NATURE, 2011, 478 (7370) :529-533